CTA Verified High Risk Coronary Plaque Predicts ACS ICONIC TRIAL

Coronary computed tomography angiography (CTA)-guided vulnerable plaque characteristics have predictive value for future acute coronary syndrome (ACS) in high-risk patients according to Incident COronary EveNts Identified by Computed Tomography (ICONIC) trial which is published in the  Journal of  the American College of Cardiology.

Continue reading

Cardiac MRI Improves Long-Term Risk Stratification After STEMI

Cardiac magnetic resonance (CMR) imaging provides useful prognostic information in revascularized ST-segment elevation (STEMI) patients, according to a recent study published in June 2018, in the Journal of the American College of Cardiology.

Continue reading

Management of Cardiogenic Shock

Dr. Naidu, Dr. Brikalis, and Dr. C. Michael Gibson Discuss

ORBITA Trial & Panel Discussion

Dr. Kirk Garratt, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss

ORBITA Trial & Panel Discussion Dr. Kirk Garratt, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss

Prior Silent MI Is Associated with Worse Outcomes in Patients with AMI

A recent observational longitudinal study published in the Journal of American College of Cardiology showed that previous silent myocardial infarction (MI) was found in 8.2% of patients presenting with first acute myocardial infarction (AMI). Previous silent MI was detected by late gadolinium enhancement- cardiac magnetic resonance (LGE-CMR). Continue reading

Pre-PCI Impella Device Improves Outcome in Acute MI complicated by Cardiogenic Shock (AMICS)

A non-randomized study published in the American Heart Journal showed increased survival rates in patients with Impella device being used as the first support strategy for patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) when invasive hemodynamic monitoring was used, and at centers with higher Impella implantation volume. Continue reading

The Use of Supplemental Oxygen in Suspected Acute MI is of no Benefit

The use of supplemental oxygen in normoxemic patients with suspected acute myocardial infarction is of no clinical benefit, says a new article in the British Medical Journal. Continue reading

EAGLES- A Randomized Clinical Trial Showing No Evidence of Smoking Cessation Treatments Association with MACE

EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), a randomized clinical trial, published in the Journal of the American Medical Association, provides evidence that smoking cessation medications do not increase the risk of serious cardiovascular events in the general population of smokers. Continue reading

Preventing Heart Attack, Stroke, and Major Adverse Limb Events in Patients with Stable Atherosclerotic Vascular Disease Dr. John Eikelboom Speaks at Brigham and Women's Hospital

High Sensitivity Troponin I and Stable Coronary Artery Disease

A recent study published in the Journal of American College of Cardiology found an association between elevated concentrations of high sensitivity troponin I (hsTnI) with increasing prevalence of coronary artery disease (CAD) in stable patients, who were suspected of coronary artery disease and underwent non-emergent coronary computed tomography angiography (CTA).

Continue reading

Does Operator PCI Volume Influence Mortality?

The number of procedures performed by the operator of a Percutaneous Coronary Intervention (PCI) in the previous year has no impact on the 30-day mortality, according to a recent UK study published in the European Heart Journal Continue reading

Do Procedure and Coronary Lesion Characteristics Impact Clinical Outcomes in Atrial Fibrillation Patients Undergoing PCI?

According to a post-hoc analysis of the PIONEER AF-PCI trial that was recently published in the Journal of American College of Cardiology,  there was no impact of complex coronary lesions, stent characteristics, or vascular approach on efficacy or safety outcomes among stented atrial fibrillation (AF) patients who received either rivaroxaban or Vitamin K Antagonists (VKA)-based dual or triple therapy. Continue reading

Should Patients with Acute Chest Pain Undergo Noninvasive Testing After the Clinical Diagnosis is Made?

The use of noninvasive cardiac tests such as coronary computed tomographic angiography (CCTA) or stress testing for patients presenting to the emergency department with chest pain is not associated with a better clinical outcome when compared to the conventional method for diagnosing acute coronary syndrome, according to a recent study published in the Journal of American Medical Association. Continue reading

Cavitation Phenomenon Damages the Endothelium and Starts the Atherosclerotic Process

Dr. Nguyen and Dr. Daaboul Discuss

Subscribe on iTunes or Google Play.

Cavitation Phenomenon Damages the Endothelium and Initiates Atherosclerosis Dr. Nguyen and Dr. Daaboul Discuss

PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndrome

Dr. Ardissino and Dr. Gibson Discuss

Subscribe on iTunes or Google Play.

PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelets in ACS Dr. Ardissino and Dr. Gibson Discuss

TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients Dr. Berwanger and Dr. Daaboul Discuss

Using High Sensitivity Troponin T in Ruling Out Acute Coronary Syndrome

High sensitivity troponin T (hsTnT) can be a reliable tool for excluding acute coronary syndrome (ACS) in very low-risk patients, according to a recent study published in the Journal of American Medical Association. Continue reading